Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Genest

Showing results (171-180 of 214) with videos related to

Pageof 22
Sort By:
Circulation Research|August 22, 2009
Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotypeNicolas Bousette, Pedro D'Orleans-Juste, Robert S Kiss, et al.
European Journal of Human Genetics : EJHG|October 22, 2009
Fine mapping and association studies of a high-density lipoprotein cholesterol linkage region on chromosome 16 in French-Canadian subjectsZari Dastani, Päivi Pajukanta, Michel Marcil, et al.
Atherosclerosis|November 26, 2013
APOE p.Leu167del mutation in familial hypercholesterolemiaZuhier Awan, Hong Y Choi, Nathan Stitziel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 29, 2005
Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsionMichel White, Haissam Haddad, Marie-Hélène Leblanc, et al.
The Canadian Journal of Cardiology|November 14, 2021
Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH RegistryGabrielle Roy, Patrick Couture, Jacques Genest, et al.
American Journal of Obstetrics and Gynecology|December 17, 2008
Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia StudySusan R Kahn, Robert Platt, Helen McNamara, et al.
Atherosclerosis|February 5, 2026
Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotypeG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
The Canadian Journal of Cardiology|December 3, 2014
Canadian Cardiovascular Society position statement on familial hypercholesterolemia, Jacques Genest, Robert A Hegele, et al.
Atherosclerosis|October 2, 2018
Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registryLiam R Brunham, Isabelle Ruel, Etienne Khoury, et al.
Lancet (London, England)|March 31, 2009
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trialPaul M Ridker, Eleanor Danielson, Francisco Ah Fonseca, et al.
Pageof 22

Showing results (171-180 of 214) with videos related to

Sort By:
Pageof 22
Circulation Research|August 22, 2009
Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotypeNicolas Bousette, Pedro D'Orleans-Juste, Robert S Kiss, et al.
European Journal of Human Genetics : EJHG|October 22, 2009
Fine mapping and association studies of a high-density lipoprotein cholesterol linkage region on chromosome 16 in French-Canadian subjectsZari Dastani, Päivi Pajukanta, Michel Marcil, et al.
Atherosclerosis|November 26, 2013
APOE p.Leu167del mutation in familial hypercholesterolemiaZuhier Awan, Hong Y Choi, Nathan Stitziel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 29, 2005
Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsionMichel White, Haissam Haddad, Marie-Hélène Leblanc, et al.
The Canadian Journal of Cardiology|November 14, 2021
Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH RegistryGabrielle Roy, Patrick Couture, Jacques Genest, et al.
American Journal of Obstetrics and Gynecology|December 17, 2008
Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia StudySusan R Kahn, Robert Platt, Helen McNamara, et al.
Atherosclerosis|February 5, 2026
Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotypeG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
The Canadian Journal of Cardiology|December 3, 2014
Canadian Cardiovascular Society position statement on familial hypercholesterolemia, Jacques Genest, Robert A Hegele, et al.
Atherosclerosis|October 2, 2018
Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registryLiam R Brunham, Isabelle Ruel, Etienne Khoury, et al.
Lancet (London, England)|March 31, 2009
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trialPaul M Ridker, Eleanor Danielson, Francisco Ah Fonseca, et al.
Pageof 22